chr7-33094814-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_203288.2(RP9):c.*420C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00647 in 182,984 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0076 ( 10 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 0 hom. )
Consequence
RP9
NM_203288.2 3_prime_UTR
NM_203288.2 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.423
Genes affected
RP9 (HGNC:10288): (RP9 pre-mRNA splicing factor) The protein encoded by this gene can be bound and phosphorylated by the protooncogene PIM1 product, a serine/threonine protein kinase . This protein localizes in nuclear speckles containing the splicing factors, and has a role in pre-mRNA splicing. CBF1-interacting protein (CIR), a corepressor of CBF1, can also bind to this protein and effects alternative splicing. Mutations in this gene result in autosomal dominant retinitis pigmentosa-9. This gene has a pseudogene (GeneID: 441212), which is located in tandem array approximately 166 kb distal to this gene. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 7-33094814-G-C is Benign according to our data. Variant chr7-33094814-G-C is described in ClinVar as [Benign]. Clinvar id is 360043.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00758 (1153/152208) while in subpopulation AFR AF= 0.0257 (1068/41520). AF 95% confidence interval is 0.0244. There are 10 homozygotes in gnomad4. There are 565 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1153 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RP9 | NM_203288.2 | c.*420C>G | 3_prime_UTR_variant | 6/6 | ENST00000297157.8 | ||
LOC124901610 | XR_007060277.1 | n.766-25G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RP9 | ENST00000297157.8 | c.*420C>G | 3_prime_UTR_variant | 6/6 | 1 | NM_203288.2 | P1 | ||
RP9 | ENST00000683432.1 | c.*1261C>G | 3_prime_UTR_variant, NMD_transcript_variant | 6/6 | |||||
RP9 | ENST00000474370.2 | downstream_gene_variant | 2 | ||||||
RP9 | ENST00000682645.1 | downstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.00756 AC: 1150AN: 152090Hom.: 10 Cov.: 32
GnomAD3 genomes
AF:
AC:
1150
AN:
152090
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00101 AC: 31AN: 30776Hom.: 0 Cov.: 0 AF XY: 0.000705 AC XY: 11AN XY: 15600
GnomAD4 exome
AF:
AC:
31
AN:
30776
Hom.:
Cov.:
0
AF XY:
AC XY:
11
AN XY:
15600
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00758 AC: 1153AN: 152208Hom.: 10 Cov.: 32 AF XY: 0.00759 AC XY: 565AN XY: 74424
GnomAD4 genome
AF:
AC:
1153
AN:
152208
Hom.:
Cov.:
32
AF XY:
AC XY:
565
AN XY:
74424
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Retinitis pigmentosa Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at